center-for-cancer-genomics-staff-research-2048x762.jpg

Center for Cancer Genomics

center-for-cancer-genomics-staff-working-in-lab-653x447.jpg

Accelerating and Applying Our Discoveries

The Center for Cancer Genomics (CCG) is part of the Precision Cancer Medicine effort at Dana-Farber Cancer Institute. CCG's mission is to facilitate the design, execution, and analysis of cancer research projects through collaborations with investigators. We continually develop and adapt new technologies to accelerate discoveries in cancer genomics and apply these discoveries to improve personalized patient care.

Our Research and Development
center-for-cancer-genomics-staff-banner-card.jpg

Our Mission: Driving Innovation in Cancer Genomics

Our team of researchers is dedicated to advancing cancer care through innovative genomic technologies.

 

  • Technology development: To develop new technologies for the analysis of cancer genomes
  • Collaborative research: To provide access to these genomic technologies to basic, translational, and clinical investigators at Dana-Farber and beyond
  • Translation: To translate technologies to the clinical setting
Meet Our Team
center-for-cancer-genomics-staff-in-lab-653x447.jpg

Collaborate With Us

The Center for Cancer Genomics continuously evaluates and develops genomic technologies for both research and clinical use. We provide a host of services that include project design, sequencing library construction, custom design and validation of hybrid capture gene panels for targeted sequencing, single-cell/nucleus workflows, bioinformatic analysis, and more.

Our Services

Contact the Center for Cancer Genomics

CCG Associate Director: Aaron Thorner
DCBC Biopsy Collections: Karla Helvie
Bioinformatics: Tony Anselmo

For general questions: 
617-582-7253 or aaron_thorner@dfci.harvard.edu